Our virtual speaker this week will be Dr. Andrew Holman, Co-founder and CEO of Inmedix. Dr. Holman, renowned Rheumatologist, will be sharing on how we can measure the effects of stress on the autonomic nervous system and the effects on the immune system.
Seattlebased medtech/biotech Inmedix, Inc., the leader in next-generation autonomic nervous system (ANS) stress testing in autoimmune disease, is bringing its signature concept, immuno-autonomics to the battle against COVID-19.